P. Olivera

发表

International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease

S. Ng, E. Louis, D. Rubin, 2021, Nature Reviews Gastroenterology & Hepatology.

Big data in IBD: a look into the future

G. Natoli, L. Peyrin-Biroulet, S. Danese, 2019, Nature Reviews Gastroenterology & Hepatology.

Safety of Janus Kinase Inhibitors in Patients with Inflammatory Bowel Diseases or Other Immune-mediated Diseases: a Systematic Review and Meta-Analysis.

S. Bonovas, L. Peyrin-Biroulet, S. Danese, 2020, Gastroenterology.

PLACEBO USE IN THE CONTEXT OF INFLAMMATORY BOWEL DISEASE CLINICAL TRIALS.

P. Olivera, J. Lasa, A. Rausch, 2020, Arquivos de gastroenterologia.

Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3.

M. Mendizabal, M. Silva, F. Bessone, 2015, World journal of hepatology.

Effectiveness of golimumab in ulcerative colitis: A review of the real world evidence.

S. Bonovas, L. Peyrin-Biroulet, S. Danese, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Surgical rates in the era of biological therapy: up, down or unchanged?

L. Peyrin-Biroulet, S. Danese, A. Spinelli, 2017, Current opinion in gastroenterology.

International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases

E. Louis, D. Rubin, L. Peyrin-Biroulet, 2021, United European gastroenterology journal.

Iron-deficiency anemia as a subclinical celiac disease presentation in an Argentinian population☆

P. Olivera, J. Lasa, L. Soifer, 2017 .

Iron-deficiency anemia as a subclinical celiac disease presentation in an Argentinian population.

P. Olivera, J. Lasa, L. Soifer, 2017, Revista de gastroenterologia de Mexico.

Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review

L. Peyrin-Biroulet, X. Roblin, A. Attar, 2016, Journal of Gastroenterology.

Value of cross-sectional imaging in assessing active Crohn's disease before stoma reversal.

L. Peyrin-Biroulet, S. Danese, L. Bresler, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis.

L. Peyrin-Biroulet, S. Danese, P. Olivera, 2021, The lancet. Gastroenterology & hepatology.

Celiac Disease and the Risk of Infertility

P. Olivera, J. Lasa, 2015 .

Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis

P. Emery, L. Peyrin-Biroulet, W. Sandborn, 2017, Alimentary pharmacology & therapeutics.

Treatment Adherence in Inflammatory Bowel Disease Patients from Argentina: A Multicenter Study

L. Peyrin-Biroulet, C. Fuxman, P. Olivera, 2020, Gastroenterology research and practice.

Treatment Persistence for Infliximab Versus Adalimumab in Crohn's Disease: A 14-Year Single-Center Experience

L. Peyrin-Biroulet, S. Danese, A. Luc, 2017, Inflammatory bowel diseases.

EFFICACY OF TACROLIMUS FOR INDUCTION OF REMISSION IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS.

P. Olivera, J. Lasa, 2017, Arquivos de gastroenterologia.

Physicians’ perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey

S. Vermeire, G. D'Haens, L. Peyrin-Biroulet, 2018, Alimentary pharmacology & therapeutics.

JAK inhibition in inflammatory bowel disease

L. Peyrin-Biroulet, S. Danese, P. Olivera, 2017, Expert review of clinical immunology.

Next generation of small molecules in inflammatory bowel disease

L. Peyrin-Biroulet, S. Danese, P. Olivera, 2016, Gut.

Biobetters in patients with immune-mediated inflammatory disorders: An international Delphi consensus.

A. Hart, L. Peyrin-Biroulet, S. Danese, 2021, Autoimmunity reviews.

Small intestinal bacterial overgrowth prevalence in celiac disease patients is similar in healthy subjects and lower in irritable bowel syndrome patients.

P. Olivera, J. Lasa, I. Zubiaurre, 2015, Revista de gastroenterologia de Mexico.

Safety of S1P Modulators in Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis

S. Bonovas, L. Peyrin-Biroulet, S. Danese, 2021, Drug Safety.

Effect of successive endoscopic procedures in polyp and adenoma detection rates: Too early is not always too good

P. Olivera, J. Lasa, I. Zubiaurre, 2020, Indian Journal of Gastroenterology.

Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugs

L. Peyrin-Biroulet, S. Danese, G. Peretto, 2023, Alimentary pharmacology & therapeutics.

Endoscopic scoring system utilization for inflammatory bowel disease activity assessment: A multicenter real-world study from Argentina

P. Olivera, L. Pereyra, F. Espinosa, 2023, Gastroenterologia y hepatologia.

Small intestinal bacterial overgrowth prevalence in celiac disease patients is similar in healthy subjects and lower in irritable bowel syndrome patients

P. Olivera, J. Lasa, I. Zubiaurre, 2015 .

Ranking treatments in the network meta-analysis should consider the certainty of evidence - Authors' reply.

L. Peyrin-Biroulet, P. Olivera, J. Lasa, 2022, The lancet. Gastroenterology & hepatology.

Challenges in the diagnosis and treatment of inflammatory bowel disease in Latin America.

G. Kaplan, R. Panaccione, A. Quaresma, 2024, The lancet. Gastroenterology & hepatology.

Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensus.

G. Peretto, P. Olivera, J. Faria-Neto, 2024, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.